プロモーションスケジュール MIRA Pharmaceuticals, Inc. Common Stock
詳細なスケジュール
簡易グラフ
会社について MIRA Pharmaceuticals, Inc. Common Stock
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. さらに詳しく| IPO date | 2023-08-03 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://mirapharmaceuticals.com |
| Цена ао | 1.03 |
| 1日あたりの価格変動: | -1.96% (1.02) |
|---|---|
| 週ごとの価格変動: | -9.09% (1.1) |
| 月ごとの料金変更: | -12.28% (1.14) |
| 3ヶ月間の価格変動: | -22.48% (1.29) |
| 半年間の価格変動: | -44.44% (1.8) |
| 年間の価格変動: | -3.84% (1.0399) |
| 年初からの価格変動: | -15.25% (1.18) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Gts Securities LLC | 37852 | 0.26 |
| Praetorian Wealth Management, Inc. | 27500 | 0.19 |
| Northern Trust Corporation | 20454 | 0.14 |
| Virtu Financial LLC | 14658 | 0.1 |
| Sandy Spring Bank | 10375 | 0.07 |
| AE Wealth Management LLC | 10000 | 0.07 |
| Royal Bank of Canada | 3500 | 0.02 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Erez Aminov | CEO & Chairman | N/A | 1978 (47 年) |
| Ms. Michelle Yanez M.B.A. | CFO, Secretary & Treasurer | N/A | 1972 (53 年) |
| Dr. Itzchak Angel Ph.D. | Chief Scientific Advisor | N/A |
住所: United States, Baltimore. MD, 855 North Wolfe Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://mirapharmaceuticals.com
Webサイト: https://mirapharmaceuticals.com
